Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Routes and Doses in Pediatric Surgery
NCT03337581Phase 4Unknown
- Sponsor
- Chinese Medical Association
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Procedural sedation (PS) (5 arms), sponsored by Chinese Medical Association. Primary endpoints: Acute Hemodynamic and respiratory Changes After Rapid Intravenous of Dexmedetomidine up to 4 months, Pharmacokinetics after a single Rapid Intravenous dose of Dexmedetomidine in Pediatric up to 6 months and 1 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT03337581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03337581.